{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:12:31Z","timestamp":1792318351543,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Innovation Project of Fujian Provincial Health Commission","award":["2024CXB001"],"award-info":[{"award-number":["2024CXB001"]}]},{"name":"National Outstanding Young Physicians Talent Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20627-y","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:02:20Z","timestamp":1791205340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radical Antegrade Modular Pancreatosplenectomy Versus Standard Resection in T3 Body and Tail Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Cohort Study"],"prefix":"10.1245","author":[{"given":"Dihang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"20627_CR1","doi-asserted-by":"publisher","first-page":"646082","DOI":"10.3389\/fonc.2021.646082","volume":"11","author":"G Li","year":"2021","unstructured":"Li G, Liao CY, Chen JZ, et al. Construction and validation of novel nomograms for predicting prognosis of pancreatic ductal adenocarcinoma after surgery according to different primary cancer locations. Front Oncol. 2021;11:646082.","journal-title":"Front Oncol"},{"key":"20627_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, et al. Pancreatic cancer. Lancet. 2025;405:1182\u2013202.","journal-title":"Lancet"},{"issue":"6","key":"20627_CR3","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/rcs.70025","volume":"20","author":"L Bencini","year":"2024","unstructured":"Bencini L, Moraldi L, Miceli E, et al. Robotic versus open distal pancreatectomy: A propensity score matching analysis. Int J Med Robot. 2024;20(6):e70025.","journal-title":"Int J Med Robot"},{"key":"20627_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1067\/msy.2003.146","volume":"133","author":"SM Strasberg","year":"2003","unstructured":"Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521\u20137.","journal-title":"Surgery"},{"key":"20627_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jamcollsurg.2006.11.002","volume":"204","author":"SM Strasberg","year":"2007","unstructured":"Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: Ability to obtain negative tangential margins. J Am Coll Surg. 2007;204:244\u20139.","journal-title":"J Am Coll Surg"},{"key":"20627_CR6","doi-asserted-by":"publisher","first-page":"109278","DOI":"10.1016\/j.surg.2025.109278","volume":"181","author":"C Ricci","year":"2025","unstructured":"Ricci C, D\u2019Ambra V, Alberici L, et al. Radical antegrade modular pancreatosplenectomy: Myth or reality? A systematic review and trial sequential meta-analysis. Surgery. 2025;181:109278.","journal-title":"Surgery"},{"key":"20627_CR7","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/cancers16081546","volume":"16","author":"J Kwon","year":"2024","unstructured":"Kwon J, Lee H, Kim H, et al. Comparison of survival outcomes between radical antegrade modular pancreatosplenectomy and conventional distal pancreatosplenectomy for pancreatic body and tail cancer: Korean multicenter propensity score match analysis. Cancers (Basel). 2024;16:1546.","journal-title":"Cancers (Basel)"},{"key":"20627_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00423-024-03265-4","volume":"409","author":"M Borys","year":"2024","unstructured":"Borys M, Wysocki M, Galazka K, et al. Laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) for adenocarcinoma of the body and tail of the pancreas - technical considerations with analysis of surgical outcomes. Langenbecks Arch Surg. 2024;409:74.","journal-title":"Langenbecks Arch Surg"},{"key":"20627_CR9","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1245\/s10434-024-15939-w","volume":"31","author":"P Li","year":"2024","unstructured":"Li P, Zhang Q, Zhang Q, et al. A LASSO cox regression predictive model for patients undergoing surgery for pancreatic body and tail adenocarcinoma patients: comparative long-term survival analysis of radical antegrade modular pancreatosplenectomy (RAMPS) and standard retrograde pancreatosplenectomy (SPRS). Ann Surg Oncol. 2024;31:8317\u201326.","journal-title":"Ann Surg Oncol"},{"key":"20627_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00423-023-02942-0","volume":"408","author":"S Sato","year":"2023","unstructured":"Sato S, Oba A, Kato T, et al. Feasibility of laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) as a standard treatment for distal resectable pancreatic cancer. Langenbecks Arch Surg. 2023;408:217.","journal-title":"Langenbecks Arch Surg"},{"key":"20627_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.asjsur.2022.09.156","volume":"46","author":"B Li","year":"2023","unstructured":"Li B, Guo S, Yin X, et al. Risk factors of positive resection margin differ in pancreaticoduodenectomy and distal pancreatosplenectomy for pancreatic ductal adenocarcinoma undergoing upfront surgery. Asian J Surg. 2023;46:1541\u20139.","journal-title":"Asian J Surg"},{"key":"20627_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pan.2023.12.003","volume":"24","author":"T Minagawa","year":"2024","unstructured":"Minagawa T, Okamura Y, Sugiura T, et al. Prognostic impact of the distance from the root of splenic artery to tumor in the patients with pancreatic body or tail cancer. Pancreatology. 2024;24:100\u20138.","journal-title":"Pancreatology"},{"key":"20627_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00423-023-03089-8","volume":"408","author":"H Ueda","year":"2023","unstructured":"Ueda H, Takahashi H, Kobayashi S, et al. Pancreatic cancer near the splenic hilum has a higher likelihood of splenic vessel invasion and unfavorable survival. Langenbecks Arch Surg. 2023;408:353.","journal-title":"Langenbecks Arch Surg"},{"key":"20627_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bjs\/znab357","volume":"109","author":"JS Kang","year":"2021","unstructured":"Kang JS, Choi YJ, Byun Y, et al. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival. Br J Surg. 2021;109:105\u201313.","journal-title":"Br J Surg"},{"key":"20627_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1245\/s10434-017-6274-8","volume":"25","author":"T Mizumoto","year":"2018","unstructured":"Mizumoto T, Toyama H, Asari S, et al. Pathological and radiological splenic vein involvement are predictors of poor prognosis and early liver metastasis after surgery in patients with pancreatic adenocarcinoma of the body and tail. Ann Surg Oncol. 2018;25:638\u201346.","journal-title":"Ann Surg Oncol"},{"key":"20627_CR16","doi-asserted-by":"publisher","first-page":"e2453588","DOI":"10.1001\/jamanetworkopen.2024.53588","volume":"8","author":"C Norton","year":"2025","unstructured":"Norton C, Shaw MS, Rubnitz Z, et al. KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma. JAMA Netw Open. 2025;8:e2453588.","journal-title":"JAMA Netw Open"},{"key":"20627_CR17","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3390\/cimb46040177","volume":"46","author":"D Stefanoudakis","year":"2024","unstructured":"Stefanoudakis D, Frountzas M, Schizas D, et al. Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer. Curr Issues Mol Biol. 2024;46:2827\u201344.","journal-title":"Curr Issues Mol Biol"},{"key":"20627_CR18","doi-asserted-by":"publisher","first-page":"e2211937120","DOI":"10.1073\/pnas.2211937120","volume":"120","author":"SS Mello","year":"2023","unstructured":"Mello SS, Flowers BM, Mazur PK, et al. Multifaceted role for p53 in pancreatic cancer suppression. Proc Natl Acad Sci U S A. 2023;120:e2211937120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1614\u20131629","key":"20627_CR19","first-page":"e1615","volume":"42","author":"CA McIntyre","year":"2024","unstructured":"McIntyre CA, Grimont A, Park J, et al. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer Cell. 2024;42(1614\u20131629):e1615.","journal-title":"Cancer Cell"},{"key":"20627_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.surg.2007.02.001","volume":"142","author":"MN Wente","year":"2007","unstructured":"Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20\u20135.","journal-title":"Surgery"},{"key":"20627_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.surg.2007.05.005","volume":"142","author":"MN Wente","year":"2007","unstructured":"Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761\u20138.","journal-title":"Surgery"},{"key":"20627_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584\u201391.","journal-title":"Surgery"},{"key":"20627_CR23","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/wjs.12630","volume":"49","author":"J Yin","year":"2025","unstructured":"Yin J, Zhang K, Huang X, et al. Comparison of radical antegrade modular pancreatosplenectomy versus standard distal pancreatectomy for pancreatic ductal adenocarcinoma: A propensity score matching study. World J Surg. 2025;49:1870\u201380.","journal-title":"World J Surg"},{"key":"20627_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ags3.12771","volume":"8","author":"T Hirashita","year":"2024","unstructured":"Hirashita T, Ikenaga N, Nakata K, et al. Prognostic significance of lymph node metastasis in pancreatic tail cancer: A multicenter retrospective study. Ann Gastroenterol Surg. 2024;8:681\u201390.","journal-title":"Ann Gastroenterol Surg"},{"key":"20627_CR25","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1002\/sim.9176","volume":"40","author":"PC Austin","year":"2021","unstructured":"Austin PC. Informing power and sample size calculations when using inverse probability of treatment weighting using the propensity score. Stat Med. 2021;40:6150\u201363.","journal-title":"Stat Med"},{"key":"20627_CR26","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/sim.1903","volume":"23","author":"JK Lunceford","year":"2004","unstructured":"Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Stat Med. 2004;23:2937\u201360.","journal-title":"Stat Med"},{"key":"20627_CR27","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00423-021-02113-z","volume":"406","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhao G, Zhao Z, et al. The standardized technique in robotic radical antegrade modular pancreatosplenectomy using the flip-up approach. Langenbecks Arch Surg. 2021;406:1697\u2013703.","journal-title":"Langenbecks Arch Surg"},{"key":"20627_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","volume":"10","author":"AL Blackford","year":"2024","unstructured":"Blackford AL, Canto MI, Dbouk M, et al. Pancreatic cancer surveillance and survival of high-risk individuals. JAMA Oncol. 2024;10:1087\u201396.","journal-title":"JAMA Oncol"},{"issue":"5","key":"20627_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.pan.2017.07.192","volume":"17","author":"R Ahola","year":"2017","unstructured":"Ahola R, Siiki A, Vasama K, Vornanen M, Sand J, Laukkarinen J. Patients with resected, histologically re-confirmed pancreatic ductal adenocarcinoma (PDAC) can achieve long-term survival despite T3 tumour or nodal involvement The Finnish Register Study 2000\u20132013. Pancreatology. 2017;17(5):822\u20136.","journal-title":"Pancreatology"},{"key":"20627_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jso.25498","volume":"120","author":"JJ Hyun","year":"2019","unstructured":"Hyun JJ, Rose JB, Alseidi AA, et al. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland. J Surg Oncol. 2019;120:262\u20139.","journal-title":"J Surg Oncol"},{"key":"20627_CR31","doi-asserted-by":"publisher","first-page":"110952","DOI":"10.1016\/j.ejrad.2023.110952","volume":"165","author":"Q Tan","year":"2023","unstructured":"Tan Q, Chen C, Wang Z, et al. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population. Eur J Radiol. 2023;165:110952.","journal-title":"Eur J Radiol"},{"key":"20627_CR32","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/cancers15041235","volume":"15","author":"R Abou Khouzam","year":"2023","unstructured":"Abou Khouzam R, Lehn JM, Mayr H, et al. Hypoxia, a targetable culprit to counter pancreatic cancer resistance to therapy. Cancers (Basel). 2023;15:1235.","journal-title":"Cancers (Basel)"},{"key":"20627_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14:14.","journal-title":"J Hematol Oncol"},{"key":"20627_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/SLA.0b013e3181cf9171","volume":"251","author":"M Kanda","year":"2010","unstructured":"Kanda M, Fujii T, Sahin TT, et al. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas. Ann Surg. 2010;251:483\u20137.","journal-title":"Ann Surg"},{"key":"20627_CR35","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1245\/s10434-022-11950-1","volume":"29","author":"K Kitamura","year":"2022","unstructured":"Kitamura K, Esaki M, Sone M, et al. Prognostic impact of radiological splenic artery involvement in pancreatic ductal adenocarcinoma of the body and tail. Ann Surg Oncol. 2022;29:7047\u201358.","journal-title":"Ann Surg Oncol"},{"key":"20627_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Di Magliano MP, et al. Pancreatic cancer: Advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"20627_CR37","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly J, Hoffman MT, Abbassi L, et al. Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discov. 2024;14:2135\u201361.","journal-title":"Cancer Discov"},{"key":"20627_CR38","doi-asserted-by":"publisher","first-page":"e2308208","DOI":"10.1002\/advs.202308208","volume":"11","author":"G Li","year":"2024","unstructured":"Li G, Liao C, Chen J, et al. Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2024;11:e2308208.","journal-title":"Adv Sci (Weinh)"},{"key":"20627_CR39","doi-asserted-by":"crossref","unstructured":"Sun K, Zhang X, Shi J, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest 2025; 135.","DOI":"10.1172\/JCI187024"},{"key":"20627_CR40","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"CY Liao","year":"2024","unstructured":"Liao CY, Li G, Kang FP, et al. Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun. 2024;15:6043.","journal-title":"Nat Commun"},{"issue":"17","key":"20627_CR41","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1158\/0008-5472.CAN-24-4784","volume":"85","author":"YD Wu","year":"2025","unstructured":"Wu YD, Huang XX, Zhang HX, et al. TRAF3IP2-AS1 deficiency induces necroptosis to promote pancreatic cancer liver metastasis. Cancer Res. 2025;85(17):3292\u2013312.","journal-title":"Cancer Res"},{"key":"20627_CR42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1126\/science.aec7929","volume":"391","author":"MT Than","year":"2026","unstructured":"Than MT, Dequiedt L, Sor R, et al. Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma. Science. 2026;391:1161\u20136.","journal-title":"Science"},{"key":"20627_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41591-024-03362-3","volume":"31","author":"AM Varghese","year":"2025","unstructured":"Varghese AM, Perry MA, Chou JF, et al. Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Nat Med. 2025;31:466\u201377.","journal-title":"Nat Med"},{"key":"20627_CR44","doi-asserted-by":"publisher","first-page":"e2025631118","DOI":"10.1073\/pnas.2025631118","volume":"118","author":"M Maddalena","year":"2021","unstructured":"Maddalena M, Mallel G, Nataraj NB, et al. TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proc Natl Acad Sci U S A. 2021;118:e2025631118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20627_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","volume":"13","author":"Y Qian","year":"2020","unstructured":"Qian Y, Gong Y, Fan Z, et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2020;13:130.","journal-title":"J Hematol Oncol"},{"key":"20627_CR46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-17-0853","volume":"24","author":"K Chaudhary","year":"2018","unstructured":"Chaudhary K, Poirion OB, Lu L, et al. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin Cancer Res. 2018;24:1248\u201359.","journal-title":"Clin Cancer Res"},{"key":"20627_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ccell.2020.05.010","volume":"38","author":"LF Escobar-Hoyos","year":"2020","unstructured":"Escobar-Hoyos LF, Penson A, Kannan R, et al. Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell. 2020;38:198-211.e198.","journal-title":"Cancer Cell"},{"key":"20627_CR48","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/cells11142155","volume":"11","author":"JA McCubrey","year":"2022","unstructured":"McCubrey JA, Yang LV, Abrams SL, et al. Effects of TP53 mutations and miRs on immune responses in the tumor microenvironment important in pancreatic cancer progression. Cells. 2022;11:2155.","journal-title":"Cells"},{"key":"20627_CR49","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, et al. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18:804\u201323.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"20627_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20627-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:05:01Z","timestamp":1791248701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20627-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":50,"alternative-id":["20627"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20627-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Chinese Clinical Trial Registry (ChiCTR2400091841); URL:\n                      \n                      .","order":2,"name":"Ethics","label":"Trial Registration","group":{"name":"EthicsHeading","label":"Ethics"}}]}}